메뉴 건너뛰기




Volumn 36, Issue 10, 1996, Pages 923-930

Influence of food on the oral bioavailability of loratadine and pseudoephedrine from extended-release tablets in healthy volunteers

Author keywords

[No Author keywords available]

Indexed keywords

CLARITIN D; LORATADINE; PSEUDOEPHEDRINE;

EID: 0029807464     PISSN: 00912700     EISSN: None     Source Type: Journal    
DOI: 10.1002/j.1552-4604.1996.tb04759.x     Document Type: Article
Times cited : (23)

References (52)
  • 1
    • 0027517934 scopus 로고
    • The pharmacology of α-adrenergic decongestants
    • Johnson DA, Hricik JG: The pharmacology of α-adrenergic decongestants. Pharmacotherapy 1993; 13:110S-115S.
    • (1993) Pharmacotherapy , vol.13
    • Johnson, D.A.1    Hricik, J.G.2
  • 2
    • 0027369881 scopus 로고
    • Pharmacokinetics of oral decongestants
    • Kanfer I, Dowse R, Vuma V: Pharmacokinetics of oral decongestants. Pharmacotherapy 1993; 13:1165-1285.
    • (1993) Pharmacotherapy , vol.13 , pp. 1165-1285
    • Kanfer, I.1    Dowse, R.2    Vuma, V.3
  • 3
    • 0016429230 scopus 로고
    • A comparison of plasma levels of L(+) pseudoephedrine after different formulations, and their relation to cardiovascular and subjective effects in man
    • Bye C, Hill HM, Hughes DTD, Peck AW: A comparison of plasma levels of L(+) pseudoephedrine after different formulations, and their relation to cardiovascular and subjective effects in man. Eur J Clin Pharmacol 1975; 8:47-53.
    • (1975) Eur J Clin Pharmacol , vol.8 , pp. 47-53
    • Bye, C.1    Hill, H.M.2    Hughes, D.T.D.3    Peck, A.W.4
  • 4
    • 0019457074 scopus 로고
    • Sensitive assay for pseudoephedrine and its metabolite, norpseudoephedrine in plasma and urine using gas-liquid chromatography with electron-capture detection
    • Lo LY, Land G, Bye A: Sensitive assay for pseudoephedrine and its metabolite, norpseudoephedrine in plasma and urine using gas-liquid chromatography with electron-capture detection. J Chromatogr Biomed Appl 1981; 222:297-302.
    • (1981) J Chromatogr Biomed Appl , vol.222 , pp. 297-302
    • Lo, L.Y.1    Land, G.2    Bye, A.3
  • 5
    • 0026089407 scopus 로고
    • The influence of diuretics in the excretion and metabolism of doping agents. VI. Pseudoephedrine
    • Delbeke FT, Debackere M: The influence of diuretics in the excretion and metabolism of doping agents. VI. Pseudoephedrine. Biopharm Drug Dispos 1991; 12:37-48.
    • (1991) Biopharm Drug Dispos , vol.12 , pp. 37-48
    • Delbeke, F.T.1    Debackere, M.2
  • 6
    • 0015359868 scopus 로고
    • Enhanced pseudoephedrine absorption by concurrent administration of aluminum hydroxide gel in humans
    • Lucarotti RL, Colaizzi JL, Barry H III, Poust RI: Enhanced pseudoephedrine absorption by concurrent administration of aluminum hydroxide gel in humans. J Pharm Sci 1972; 61:903-905.
    • (1972) J Pharm Sci , vol.61 , pp. 903-905
    • Lucarotti, R.L.1    Colaizzi, J.L.2    Barry III, H.3    Poust, R.I.4
  • 7
    • 0018662307 scopus 로고
    • Urinary excretion of chlorpheniramine and pseudoephedrine in humans
    • Lai CM, Stoll RG, Look ZM, Yacobi A: Urinary excretion of chlorpheniramine and pseudoephedrine in humans. J Pharm Sci 1979; 68:1243-1246.
    • (1979) J Pharm Sci , vol.68 , pp. 1243-1246
    • Lai, C.M.1    Stoll, R.G.2    Look, Z.M.3    Yacobi, A.4
  • 9
    • 0018731035 scopus 로고
    • Comparison of GLC and high-pressure liquid chromatographic methods for analysis of urinary pseudoephedrine
    • Baaske DM, Lai C-M, Klein L, Look ZM, Yacobi A: Comparison of GLC and high-pressure liquid chromatographic methods for analysis of urinary pseudoephedrine. J Pharm Sci 1979; 68:1472.
    • (1979) J Pharm Sci , vol.68 , pp. 1472
    • Baaske, D.M.1    Lai, C.-M.2    Klein, L.3    Look, Z.M.4    Yacobi, A.5
  • 10
    • 0014980134 scopus 로고
    • The influence of urinary pH on the half-life of pseudoephedrine in man and dog and a sensitive assay for its determination in human plasma
    • Kuntzman RG, Tsai I, Brand L, Mark LC: The influence of urinary pH on the half-life of pseudoephedrine in man and dog and a sensitive assay for its determination in human plasma. Clin Pharmacol Ther 1971; 12:62-67.
    • (1971) Clin Pharmacol Ther , vol.12 , pp. 62-67
    • Kuntzman, R.G.1    Tsai, I.2    Brand, L.3    Mark, L.C.4
  • 12
    • 0023118299 scopus 로고
    • Influence of a standard meal on the absorption of controlled-release pseudoephedrine capsules
    • Wecker MT, Graves DA, Amsel LP, Hinsvark ON: Influence of a standard meal on the absorption of controlled-release pseudoephedrine capsules. J Pharm Sci 1987; 76:29-31.
    • (1987) J Pharm Sci , vol.76 , pp. 29-31
    • Wecker, M.T.1    Graves, D.A.2    Amsel, L.P.3    Hinsvark, O.N.4
  • 14
    • 0018241207 scopus 로고
    • Dose tolerance and pharmacokinetic studies of L(+) pseudoephedrine capsules in man
    • Dickerson J, Perrier D, Mayersohn M, Bressler R: Dose tolerance and pharmacokinetic studies of L(+) pseudoephedrine capsules in man. Eur J Clin Pharmacol 1978; 14:253-259.
    • (1978) Eur J Clin Pharmacol , vol.14 , pp. 253-259
    • Dickerson, J.1    Perrier, D.2    Mayersohn, M.3    Bressler, R.4
  • 15
    • 77956935139 scopus 로고
    • Pseudoephedrine hydrochloride
    • Florey K (ed.): New York: Academic Press
    • Benezra SA, McRae JW: Pseudoephedrine hydrochloride. In, Florey K (ed.): Analytical Profiles of Drug Substances. New York: Academic Press, 1979; 489-507.
    • (1979) Analytical Profiles of Drug Substances , pp. 489-507
    • Benezra, S.A.1    McRae, J.W.2
  • 16
    • 0021263892 scopus 로고
    • Evaluation of the CNS properties of loratadine (SCH 29851), a potential nonsedating antihistamine
    • Barnett A, Iorio LC, Kreutner W, Tozzi S, Ahn HS, Gulbenkian A: Evaluation of the CNS properties of loratadine (SCH 29851), a potential nonsedating antihistamine. Agents Actions 1984; 14:590-597.
    • (1984) Agents Actions , vol.14 , pp. 590-597
    • Barnett, A.1    Iorio, L.C.2    Kreutner, W.3    Tozzi, S.4    Ahn, H.S.5    Gulbenkian, A.6
  • 17
    • 0004021418 scopus 로고
    • Comparison of efficacy and safety of SCH 29851, terfenadine and placebo in treatment of seasonal rhinitis
    • Bedard PM, Del Carpio J, Gutkowski A, Hebert J, Prevost M, Schulz J, et al: Comparison of efficacy and safety of SCH 29851, terfenadine and placebo in treatment of seasonal rhinitis (abstract). Ann Allergy 1985; 55:233.
    • (1985) Ann Allergy , vol.55 , pp. 233
    • Bedard, P.M.1    Del Carpio, J.2    Gutkowski, A.3    Hebert, J.4    Prevost, M.5    Schulz, J.6
  • 21
    • 0023094591 scopus 로고
    • Antiallergic activity of loratadine, a nonsedating antihistamine
    • Kreutner W, Chapman RW, Gulbenkian A, Siegel M: Antiallergic activity of loratadine, a nonsedating antihistamine. Allergy 1987; 42:57-63.
    • (1987) Allergy , vol.42 , pp. 57-63
    • Kreutner, W.1    Chapman, R.W.2    Gulbenkian, A.3    Siegel, M.4
  • 22
    • 0024367950 scopus 로고
    • Efficacy and safety of loratadine (10 mg once daily), terfenadine (60 mg twice daily), and placebo in the treatment of seasonal allergic rhinitis
    • Del Carpio I, Kabbash L, Turenne Y, Prevost M, Hebert J, Bedard PM, et al: Efficacy and safety of loratadine (10 mg once daily), terfenadine (60 mg twice daily), and placebo in the treatment of seasonal allergic rhinitis. J Allergy Clin Immunol 1989; 84:741-746.
    • (1989) J Allergy Clin Immunol , vol.84 , pp. 741-746
    • Del Carpio, I.1    Kabbash, L.2    Turenne, Y.3    Prevost, M.4    Hebert, J.5    Bedard, P.M.6
  • 23
    • 0023091016 scopus 로고
    • Loratadine (SCH 29851) 40 mg once daily versus terfenadine 60 mg twice daily in the treatment of allergic rhinitis
    • Bruttmann G, Pedrali P: Loratadine (SCH 29851) 40 mg once daily versus terfenadine 60 mg twice daily in the treatment of allergic rhinitis. J Int Med Res 1987; 15:63-70.
    • (1987) J Int Med Res , vol.15 , pp. 63-70
    • Bruttmann, G.1    Pedrali, P.2
  • 28
    • 0028593587 scopus 로고
    • Loratadine, a reappraisal of its pharmacological properties and therapeutics in allergic disorders
    • Haria M, Fitton A, Peters DH: Loratadine, a reappraisal of its pharmacological properties and therapeutics in allergic disorders. Drugs 1994; 48:617-637.
    • (1994) Drugs , vol.48 , pp. 617-637
    • Haria, M.1    Fitton, A.2    Peters, D.H.3
  • 29
    • 0024556615 scopus 로고
    • Loratadine: A preliminary review of its pharmacodynamic properties and therapeutic efficacy
    • Clissold S, Sorkin E, Goa K: Loratadine: a preliminary review of its pharmacodynamic properties and therapeutic efficacy. Drugs 1989; 37:42-57.
    • (1989) Drugs , vol.37 , pp. 42-57
    • Clissold, S.1    Sorkin, E.2    Goa, K.3
  • 30
    • 0026729605 scopus 로고
    • New data on the safety of loratadine
    • Van Cauwenberge P: New data on the safety of loratadine. Drug Invest 1992; 4:283-291.
    • (1992) Drug Invest , vol.4 , pp. 283-291
    • Van Cauwenberge, P.1
  • 31
    • 0019969141 scopus 로고
    • A double-blind controlled evaluation of Actified and its individual constituents in allergic rhinitis
    • Connell JT, Williams BO, Allen S, Cato A, Perkins JG: A double-blind controlled evaluation of Actified and its individual constituents in allergic rhinitis. J Int Med Res 1982; 10:341-347.
    • (1982) J Int Med Res , vol.10 , pp. 341-347
    • Connell, J.T.1    Williams, B.O.2    Allen, S.3    Cato, A.4    Perkins, J.G.5
  • 32
    • 0019513561 scopus 로고
    • An evaluation of tripolidine and pseudoephedrine in the treatment of allergic rhinitis
    • Diamond L, Gerson K, Cato A, Peace K, Perkins JG: An evaluation of tripolidine and pseudoephedrine in the treatment of allergic rhinitis. Ann Allergy 1981; 47:87-91.
    • (1981) Ann Allergy , vol.47 , pp. 87-91
    • Diamond, L.1    Gerson, K.2    Cato, A.3    Peace, K.4    Perkins, J.G.5
  • 33
    • 0018909921 scopus 로고
    • Controlled comparison of a new antihistamine-decongestant combination to its individual components
    • Falliers CJ, Redding MA: Controlled comparison of a new antihistamine-decongestant combination to its individual components. Ann Allergy 1980; 45:75-80.
    • (1980) Ann Allergy , vol.45 , pp. 75-80
    • Falliers, C.J.1    Redding, M.A.2
  • 34
    • 0016442138 scopus 로고
    • A double-blind crossover trial of pseudoephedrine and tripolidine alone and in combination for the treatment of allergic rhinitis
    • Empey DW, Dye C, Hodder M, Hughes DTD: A double-blind crossover trial of pseudoephedrine and tripolidine alone and in combination for the treatment of allergic rhinitis. Ann Allergy 1975; 34:41-46.
    • (1975) Ann Allergy , vol.34 , pp. 41-46
    • Empey, D.W.1    Dye, C.2    Hodder, M.3    Hughes, D.T.D.4
  • 35
    • 0018356454 scopus 로고
    • A novel method to assess antihistamine and decongestant efficacy
    • Connell JT: A novel method to assess antihistamine and decongestant efficacy. Ann Allergy 1979; 42:278-285.
    • (1979) Ann Allergy , vol.42 , pp. 278-285
    • Connell, J.T.1
  • 36
    • 0014082674 scopus 로고
    • Combination therapy in hay fever and allergic rhinitis
    • Thomson WAR, Garland J (eds): Combination therapy in hay fever and allergic rhinitis. Practitioner 1967; 198:713-716.
    • (1967) Practitioner , vol.198 , pp. 713-716
    • Thomson, W.A.R.1    Garland, J.2
  • 38
    • 1842506125 scopus 로고
    • Loratadine and pseudoephedrine sulfate: A double-blind, placebo-controlled comparison of a combination tablet (SCH 434) and its individual components in seasonal allergic rhinitis
    • Hebert J, Bedard PM, Del Carpio J, Drouin M, Gutkowski A, Kabbash LG, et al: Loratadine and pseudoephedrine sulfate: a double-blind, placebo-controlled comparison of a combination tablet (SCH 434) and its individual components in seasonal allergic rhinitis. Am J Rhinol 1988; 2:71-75.
    • (1988) Am J Rhinol , vol.2 , pp. 71-75
    • Hebert, J.1    Bedard, P.M.2    Del Carpio, J.3    Drouin, M.4    Gutkowski, A.5    Kabbash, L.G.6
  • 40
    • 0028260312 scopus 로고
    • Sensitive gas-liquid chromatographic method for the determination of loratadine and its major active metabolite, descarboethoxyloratadine in human plasma using a nitrogen-phosphorus detector
    • Johnson R, Christensen J, Lin C-C: Sensitive gas-liquid chromatographic method for the determination of loratadine and its major active metabolite, descarboethoxyloratadine in human plasma using a nitrogen-phosphorus detector. J Chromatogr 1994; 657:125-131.
    • (1994) J Chromatogr , vol.657 , pp. 125-131
    • Johnson, R.1    Christensen, J.2    Lin, C.-C.3
  • 43
    • 78651147390 scopus 로고
    • Kinetic analysis of blood levels and urinary excretion in the absorptive phase after single dose of drug
    • Wagner JG, Nelson E: Kinetic analysis of blood levels and urinary excretion in the absorptive phase after single dose of drug. J Pharm Sci 1964; 53:1392-1394.
    • (1964) J Pharm Sci , vol.53 , pp. 1392-1394
    • Wagner, J.G.1    Nelson, E.2
  • 44
    • 0023615056 scopus 로고
    • A comparison of the two one-sided tests procedure and the power approach for assessing the equivalence of average bioavailability
    • Schuirmann DJ: A comparison of the two one-sided tests procedure and the power approach for assessing the equivalence of average bioavailability. J Pharmacokinet Biopharm 1987; 15:657-680.
    • (1987) J Pharmacokinet Biopharm , vol.15 , pp. 657-680
    • Schuirmann, D.J.1
  • 46
    • 0017383466 scopus 로고
    • Influence of food and diet on gastrointestinal drug absorption: A review
    • Welling PG: Influence of food and diet on gastrointestinal drug absorption: a review. J Pharmacokinet Biopharm 1977; 5:291-334.
    • (1977) J Pharmacokinet Biopharm , vol.5 , pp. 291-334
    • Welling, P.G.1
  • 47
    • 0028831612 scopus 로고
    • Pharmacokinetic considerations in gastrointestinal motor disorders
    • Hebbard GS, Sun WM, Bochner F, Horowitz M: Pharmacokinetic considerations in gastrointestinal motor disorders. Clin Pharmacokinet 1995; 28:41-66.
    • (1995) Clin Pharmacokinet , vol.28 , pp. 41-66
    • Hebbard, G.S.1    Sun, W.M.2    Bochner, F.3    Horowitz, M.4
  • 48
    • 0028966473 scopus 로고
    • In vitro and in vivo evaluation of a once-daily controlled-release pseudoephedrine product
    • Hwang SS, Gorsline J, Louie J, Dye D, Guinta D, Hamel L: In vitro and in vivo evaluation of a once-daily controlled-release pseudoephedrine product. J Clin Pharmacol 1995; 35:259-267.
    • (1995) J Clin Pharmacol , vol.35 , pp. 259-267
    • Hwang, S.S.1    Gorsline, J.2    Louie, J.3    Dye, D.4    Guinta, D.5    Hamel, L.6
  • 49
    • 0025940081 scopus 로고
    • Effect of food on bioavailability of pseudoephedrine and brompheniramine administered from a gastrointestinal therapeutic system
    • Chao ST, Prather D, Pinson D, Coen P, Pruitt B, Knowles M, Place V: Effect of food on bioavailability of pseudoephedrine and brompheniramine administered from a gastrointestinal therapeutic system. J Pharm Sci 1991; 80:432-435.
    • (1991) J Pharm Sci , vol.80 , pp. 432-435
    • Chao, S.T.1    Prather, D.2    Pinson, D.3    Coen, P.4    Pruitt, B.5    Knowles, M.6    Place, V.7
  • 50
    • 0017655989 scopus 로고
    • Enhancement of the bioavailability of propranolol and metoprolol by food
    • Melander A, Danielson K, Schersten B, Wahlin E: Enhancement of the bioavailability of propranolol and metoprolol by food. Clin Pharmacol Ther 1977; 30:108-112.
    • (1977) Clin Pharmacol Ther , vol.30 , pp. 108-112
    • Melander, A.1    Danielson, K.2    Schersten, B.3    Wahlin, E.4
  • 52


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.